Yes — for type 2 diabetes, with prior authorization. Anthem's drug lists put Ozempic pens and the Ozempic oral tablet on Tier 2 with prior authorization (PA) and a quantity limit. Unlike Wegovy or Zepbound, the Ozempic row has no "BE" (benefit exclusion) flag, because Ozempic is a type 2 diabetes drug, not a weight-loss brand. Ozempic is not FDA-approved for weight loss — that brand is Wegovy (same active ingredient, semaglutide, different label).
So: do you have type 2 diabetes documented the way Anthem asks, and can your prescriber show the PA criteria below? This page answers both from Anthem's published lists and the Formulary Navigator GLP-1 criteria.
The quick answer by Anthem plan type
Find your Anthem card type first.
| Your Anthem plan | Does it cover Ozempic? | What decides it |
|---|---|---|
| Employer plan (job-based) | Usually yes for type 2 diabetes, at Tier 2 with PA and a quantity limit | Your plan's drug list, the PA criteria, and a documented T2D diagnosis |
| Individual or family plan you bought yourself | Usually yes for type 2 diabetes, same list pattern | Your plan's drug list and benefit documents |
| Anthem Blue Cross Medi-Cal (California Medicaid) | Yes for type 2 diabetes only; not for weight loss since January 1, 2026 | State Medi-Cal Rx rules (Code I diabetes restriction) |
| Other Anthem Medicaid plans | Depends on your state's Medicaid rules | Your state's Medicaid drug list |
| Anthem Medicare Advantage or Part D | Often for type 2 diabetes under Part D rules — not through Medicare's weight-loss GLP-1 Bridge | Your plan's Part D formulary; see does Medicare cover Ozempic |
Sources: Anthem National Drug List, Three Tier, effective October 1, 2026, Anthem Medi-Cal GLP-1 notice, Medicare.gov weight-loss drugs. Checked November 7, 2026.
The right next step depends on your plan type, whether type 2 diabetes is on record, your state, and whether you'd pay cash while you wait. Find My GLP-1 Path asks a few questions and shows paths that fit.
See which GLP-1 path fits your Anthem plan
What Anthem's drug list actually says about Ozempic
On Anthem's National Drug List (Three Tier, current as of October 1, 2026), every Ozempic product we found sits on Tier 2 with two notes: PA and QL. There is no BE flag and no ST (step therapy) flag on the list itself.
Here is what each note means, in Anthem's words:
- PA (prior authorization): "You may need to get benefits approved before certain prescriptions can be filled." Your prescriber has to get permission before the pharmacy can bill Anthem.
- QL (quantity limit): there's a cap on how much the plan covers in a set time.
- BE (benefit exclusion) — not on Ozempic: "This drug may not be covered depending on your plans design." That flag appears on weight-loss GLP-1s like Wegovy and Zepbound, not on Ozempic.
We found the same Ozempic pattern — Tier 2, PA; QL — on Anthem's National Four Tier and Essential Three Tier lists for Virginia, also effective October 1, 2026. These are the published Virginia versions. Your state's list can differ, so treat them as the pattern, not your personal answer.
How Ozempic compares with other GLP-1s on the same Anthem list
| Drug (form) | Tier | Notes on the list | What that tells you |
|---|---|---|---|
| Ozempic (0.25/0.5, 1 mg, 2 mg pens) | 2 | PA; QL — no BE, no ST | Type 2 diabetes drug. Coverage is about PA, not a weight-loss exclusion |
| Ozempic oral tablet | 2 | PA; QL — no BE, no ST | Same treatment as the pens on this list |
| Rybelsus (oral tablet) | 2 | PA; QL — no BE, no ST | Another semaglutide diabetes tablet |
| Mounjaro (auto-injector) | 2 | PA; QL — no BE | Type 2 diabetes drug (tirzepatide) |
| Trulicity (auto-injector) | 2 | PA; QL — no BE | Type 2 diabetes drug |
| Wegovy (pen), Wegovy HD, Wegovy pill | 2 | PA; BE; QL | Weight-loss drug. Coverage depends on whether your plan bought that benefit |
| Foundayo (pill) | 2 | PA; BE; QL | Same weight-loss treatment as Wegovy on this list |
Source: Anthem National Drug List, Three Tier, checked November 7, 2026.
Two things jump out. First, Ozempic is treated like Mounjaro and Trulicity — diabetes lane, no BE flag — not like Wegovy. Second, the missing ST flag on the list does not mean Anthem skips every "try something first" rule. The published PA criteria still ask for a metformin trial (or a listed exception). See the criteria section below.
If your goal is weight loss without type 2 diabetes, Ozempic is the wrong brand to fight Anthem over. Check what GLP-1 does Anthem cover for Wegovy and Zepbound rules instead. For the Ozempic vs Wegovy label split, see Ozempic vs Wegovy.
Does your Anthem plan cover Ozempic? How to find out
A PA denial and a "not covered" screen look alike at the pharmacy, but they're different problems. Check which one you have before you spend weeks on paperwork:
- Log in at anthem.com or open the Sydney Health app. Use "Price a Medication." Search "Ozempic."
- Read the result. "Covered with prior authorization" is the usual diabetes-lane answer. "Not covered" needs a call — it can mean plan design, quantity, or diagnosis.
- Call Pharmacy Member Services on your ID card: "Is Ozempic covered for type 2 diabetes with prior authorization, and what is my Tier 2 cost share?"
- Ask HR only if the app says the drug isn't a covered benefit at all. That's less common for Ozempic than for Wegovy, because Ozempic isn't flagged BE on these lists.
Don't want to make the calls? Ro's insurance team checks whether your plan may cover Ozempic and handles PA paperwork. Ro says only the Wegovy pen, Zepbound autoinjector pen, and Ozempic are available for insurance coverage through Ro right now. The check is free; the Ro membership is separate and insurance doesn't pay for it (Ro insurance).
Check your Anthem Ozempic coverage with Ro (sponsored affiliate link, opens in a new tab)
Anthem's Ozempic prior authorization criteria, in plain English
If Ozempic is on your plan, the PA decides whether Anthem pays. The GLP-1 / GIP–GLP-1 clinical criteria on Formulary Navigator (dated October 27, 2026) set out what a preferred Ozempic request must show. Initial approvals last up to 1 year.
To start Ozempic (injection or oral tablet) as a preferred request, you need all of this:
| Requirement | What it means for you |
|---|---|
| Age 18 or older | Adults only for Ozempic under these criteria |
| Type 2 diabetes diagnosis | Prediabetes or "weight loss only" does not meet this path |
| Proof of that diagnosis | A1C of 6.5% or higher, or fasting plasma glucose of 126 mg/dL or higher (after ≥8 hours fasting), or a 2-hour oral glucose tolerance result of 200 mg/dL or higher, or hyperglycemia symptoms (or hyperglycemic crisis) with a random glucose of 200 mg/dL or higher |
| And one of these | A trial of metformin with inadequate response or intolerance (samples and coupon fills don't count), or a contraindication to metformin, or a history of atherosclerotic cardiovascular disease (ASCVD) such as heart attack, stroke, angina, coronary disease, revascularization, TIA, or peripheral artery disease, or (for Ozempic injection) type 2 diabetes with chronic kidney disease |
Quantity limits in the same criteria document: about one pen per 28 days for each Ozempic injection strength; for tablets, a one-time 30-tablet bottle of the 1.5 mg start dose, then one 4 mg or 9 mg tablet per day.
To keep Ozempic (continuation): you still need to be 18 or older (for Ozempic) with type 2 diabetes verified the same way. The continuation path in this document does not add a separate "percent weight loss" rule — that is a weight-loss-drug rule, not this diabetes criteria set.
These criteria will not approve Ozempic if: you have MEN 2 or a personal or family history of medullary thyroid cancer; you would use it with another GLP-1 (including Wegovy, Zepbound, Foundayo, Saxenda, Soliqua or Xultophy); or you would use it with a DPP-4 inhibitor (drugs such as Januvia / sitagliptin and related combos).
Source: GLP-1 / GIP–GLP-1 clinical criteria on Formulary Navigator, dated October 27, 2026, checked November 7, 2026. The PDF attributes itself to "the health plan"; it is the criteria document hosted on Formulary Navigator, the platform that publishes Anthem's drug lists.
The paperwork step most people trip on
Missing labs and a fuzzy metformin history stall many requests. Before your prescriber submits, gather a clear type 2 diabetes diagnosis, recent A1C or qualifying glucose labs, metformin trial/intolerance/contraindication notes (unless you qualify through ASCVD or, for the injection, CKD), and a request that is not written as weight loss alone. More context: Ozempic prior authorization.
Ro's insurance concierge submits Ozempic PA paperwork and works with your insurer (Ro says about 1 to 3 weeks; PA reviews often 1 to 2 weeks). It can't change what your plan covers. Ro says Medicaid and some other government-funded plans aren't currently eligible.
Let Ro's insurance team handle the Anthem paperwork (sponsored affiliate link, opens in a new tab)
What Ozempic costs with Anthem
If Anthem covers Ozempic, you pay your Tier 2 copay or coinsurance. Use "Price a Medication" in the app for your number. Broader context: Ozempic cost with insurance.
Novo's commercial offer may lower that copay to as little as $25 for a one-, two-, or three-month fill, with max savings of $100 per month ($200 / $300 for multi-month), for up to 48 months from enrollment. Medicare, Medicaid, VA, DOD, TRICARE and similar are excluded. Novo's terms say Affordable Care (Health Exchange) plans, FEHB, and state employee plans are not government programs for this offer. Accumulator and maximizer plans can block the card (savings card terms; Ozempic savings, checked November 7, 2026). See Ozempic savings card.
If Anthem doesn't cover your fill, NovoCare self-pay is the manufacturer cash path. As of November 7, 2026, new patients pay $199 a month for 0.25 mg and 0.5 mg pens for two fills through December 31, 2026, then $349 (0.25/0.5/1 mg) or $499 (2 mg); one month = one pen box. Tablets start at $149 (1.5 mg, new patients), $199 (4 mg), and $299 (9 mg). List (WAC) price is $1,027.51 per pen or tablet bottle (NovoPricing; NovoCare). Self-pay usually does not count toward your Anthem deductible or out-of-pocket maximum.
Ro helps with insurance for Ozempic, but Ro's pricing page does not list an Ozempic cash price. It lists cash prices for other GLP-1s (Wegovy pill and Foundayo from $149, Wegovy pen from $199, Zepbound KwikPen from $299) and says those match LillyDirect, NovoCare and TrumpRx. Membership is separate: $39 first month (refunded if not eligible), then $74–$149/month (Ro pricing, checked November 7, 2026). Ro's Ozempic page says without insurance you can pay about $900–$1,100 list plus membership (Ro Ozempic).
| Situation | What you'd likely pay |
|---|---|
| Anthem covers Ozempic + you qualify for Novo's commercial offer | As little as $25 per fill under the card's terms and caps |
| Anthem covers Ozempic, no savings card | Your Tier 2 copay or coinsurance (check the Anthem app) |
| Anthem denies or delays, NovoCare self-pay pens | $199/month for the first two 0.25/0.5 mg fills (through Dec 31, 2026), then $349 or $499 by dose |
| Anthem denies or delays, other cash GLP-1s through Ro | Compare Ro's listed cash prices for Wegovy, Foundayo or Zepbound + Ro membership — not an Ozempic cash price on Ro's pricing page |
Compare Ro's cash prices for other GLP-1s (sponsored affiliate link, opens in a new tab)
If Anthem denies Ozempic
Read the denial letter. Common gaps: weight-loss-only wording without type 2 diabetes, missing or old labs, no metformin trial/intolerance or ASCVD/CKD exception, or a quantity over the limit.
Fixable denial: ask your prescriber what was missing and resubmit, or appeal (how to appeal an Ozempic denial; GLP-1 appeal levels).
No type 2 diabetes: Ozempic is usually the wrong fight. Ask about Wegovy, Zepbound or Foundayo (BE-flagged on Anthem's lists), or compare cash paths (if insurance doesn't cover weight-loss medication).
Anthem Medi-Cal, Medicaid and Medicare
Anthem Blue Cross Medi-Cal (California): Since January 1, 2026, Ozempic stays on the Medi-Cal Rx list only with a type 2 diabetes diagnosis restriction. It is not eligible for weight-loss indications. Claims that fail the diagnosis rule deny with Reject Code 80. PA requests for non-weight-loss indications are reviewed for medical necessity (Anthem Medi-Cal GLP-1 notice).
Other Anthem Medicaid plans: your state's Medicaid program sets the rules. See does Medicaid cover Ozempic. Ro says Medicaid patients aren't currently eligible for its program, so it isn't a path here.
Anthem Medicare plans: Medicare's GLP-1 Bridge is a weight-management path and does not make Ozempic a Bridge drug. Ozempic coverage for type 2 diabetes, when available, runs through Part D / Medicare Advantage drug lists instead. Check your Evidence of Coverage and does Medicare cover Ozempic. Novo's $25 commercial offer excludes Medicare members; Novo's self-pay options may still be available under its own terms.
Which path fits you
| If you… | Your best next step |
|---|---|
| Have type 2 diabetes on an Anthem commercial plan | Confirm Tier 2 + PA in the app, gather labs and metformin/ASCVD/CKD notes, then submit |
| Have ASCVD or CKD with type 2 diabetes | Bring those records — they can meet the criteria without a metformin trial |
| Were prescribed Ozempic for weight loss only | Ask about Wegovy or Zepbound instead; Ozempic isn't FDA-approved for weight loss |
| Have an Anthem Medi-Cal card | Coverage is for type 2 diabetes only under state rules |
| Have Medicare | Check your Part D formulary; Bridge is not the Ozempic path |
| Need help with the Anthem paperwork | Ro's insurance concierge handles Ozempic PA for eligible commercial plans |
| Need a cash option while you wait | Use NovoCare's Ozempic self-pay prices, or compare other GLP-1 cash prices |
Safety before you ask Anthem
Do not use Ozempic if you or a family member has had medullary thyroid cancer (MTC), or if you have multiple endocrine neoplasia syndrome type 2 (MEN 2). Ozempic has a boxed warning about thyroid C-cell tumors. Tell your prescriber if you're pregnant or planning a pregnancy (the label says to discontinue at least 2 months before a planned pregnancy). Get care right away for severe stomach pain that won't go away (Ozempic prescribing information, revised May 2026).
What we actually verified
The RX Index is the independent GLP-1 decision resource that scores telehealth providers and treatment paths on clinical legitimacy, care quality, transparency, access, and cost, so readers can choose the path that fits their situation.
On November 7, 2026, we:
- Read Anthem's Virginia National Drug Lists (Three Tier, Four Tier) and Essential Three Tier list, effective October 1, 2026, and recorded the Ozempic, Rybelsus, Trulicity, Mounjaro, Wegovy and Foundayo rows and the PA, BE, QL and ST definitions.
- Read the GLP-1 / GIP–GLP-1 clinical criteria document on Formulary Navigator (dated October 27, 2026), including quantity limits, continuation rules and exclusions.
- Read Anthem's Medi-Cal GLP-1 notice, the Ozempic prescribing information (revised May 2026), NovoCare and Ozempic.com savings pages, NovoPricing, and Ro's pricing, insurance and Ozempic pages.
What we could not confirm: your own plan's drug list and benefit design, the drug list for every Anthem state, and your exact copay. Only your plan documents or Anthem's member tools can tell you those. No web page, including this one, can tell you whether you'll be approved. Anthem decides, based on what your prescriber sends.
Frequently asked questions
Does Anthem cover Ozempic for type 2 diabetes?
Usually yes, with prior authorization. Anthem's drug lists we checked show Ozempic pens and the oral tablet on Tier 2 with PA and a quantity limit, and without the weight-loss benefit-exclusion flag that appears on Wegovy and Zepbound.
Does Anthem cover Ozempic for weight loss?
Not as a weight-loss drug. Ozempic is not FDA-approved for weight loss, and Anthem's diabetes PA criteria require a type 2 diabetes diagnosis. For weight loss, the brands to check are Wegovy, Zepbound or Foundayo — and those rows carry a possible benefit exclusion.
Does Anthem require prior authorization for Ozempic?
Yes. Every Anthem list we checked marks Ozempic "PA." The Formulary Navigator criteria (dated October 27, 2026) ask for age 18+, verified type 2 diabetes, and a metformin trial or a listed exception (metformin contraindication, ASCVD, or — for the injection — chronic kidney disease).
Do I have to try metformin before Ozempic on Anthem?
Often, yes — unless you have a metformin contraindication, a qualifying ASCVD history, or (for Ozempic injection) type 2 diabetes with chronic kidney disease. The drug list itself has no ST flag, but the PA criteria still include that metformin step.
How long does an Anthem Ozempic approval last?
Under the posted criteria, approvals last up to 1 year. Continuations re-check age and the type 2 diabetes verification rules.
Does Anthem cover the Ozempic pill (oral tablet)?
On the Virginia lists we checked, "OZEMPIC ORAL TABLET" appears on Tier 2 with PA and QL, same as the pens. Your state's list can differ.
Can I use the Ozempic savings card with Anthem?
If you have commercial Anthem coverage that covers Ozempic, Novo says you may pay as little as $25 under its terms and monthly caps. People on Medicare, Medicaid or other government programs can't use the commercial offer. Marketplace (Health Exchange) plans are not treated as government programs for this offer, per Novo's terms.
Can Ro help me get Ozempic covered by Anthem?
Ro's insurance concierge checks your coverage and handles PA paperwork for Ozempic (and for Wegovy pens and Zepbound autoinjector pens). It can't override a hard plan exclusion. Ro says Medicaid patients aren't currently eligible. Ro's pricing page does not list an Ozempic cash price.
Sources
- Anthem: Drug list and formulary page; National Drug List, Three Tier (Virginia), effective October 1, 2026; National Drug List, Four Tier (Virginia); Essential Drug List, Three Tier (Virginia) (all checked November 7, 2026)
- GLP-1 / GIP–GLP-1 clinical criteria, Formulary Navigator (dated October 27, 2026; checked November 7, 2026)
- Anthem Blue Cross Medi-Cal: GLP-1 coverage considerations (checked November 7, 2026)
- Medicare.gov: weight-loss drugs and the GLP-1 Bridge (checked November 7, 2026)
- Novo Nordisk: Ozempic prescribing information (revised May 2026); NovoCare Ozempic savings; Ozempic.com savings; diabetes savings card terms; NovoPricing (all checked November 7, 2026)
- Ro: pricing, insurance, and Ozempic (checked November 7, 2026)
Related: What GLP-1 does Anthem cover, GLP-1 providers that accept Anthem, does insurance cover Ozempic, Ozempic cost with insurance, Ozempic prior authorization, does Medicare cover Ozempic.
Still not sure which GLP-1 path fits you? Take The RX Index's free Find My GLP-1 Path quiz — about 2 minutes, no signup.